BioForce Nanosciences Holdings, Inc.
BFNH
$0.60
$0.2466.67%
09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
---|---|---|---|---|---|
Revenue | -- | -- | -- | -- | -- |
Total Other Revenue | -- | -- | -- | -- | -- |
Total Revenue | -- | -- | -- | -- | -- |
Cost of Revenue | -- | -- | -- | -- | -- |
Gross Profit | -- | -- | -- | -- | -- |
SG&A Expenses | 122.00K | 114.40K | 130.80K | 114.40K | 113.60K |
Depreciation & Amortization | -- | -- | -- | -- | -- |
Other Operating Expenses | -- | -- | -- | -- | -- |
Total Operating Expenses | 122.00K | 114.40K | 130.80K | 114.40K | 113.60K |
Operating Income | -122.00K | -114.40K | -130.80K | -114.40K | -113.60K |
Income Before Tax | -122.00K | -114.40K | -130.80K | -114.40K | -113.60K |
Income Tax Expenses | -- | -- | -- | -- | -- |
Earnings from Continuing Operations | -122.00K | -114.40K | -130.80K | -114.40K | -113.60K |
Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | -- | -- | -- | -- | -- |
Net Income | -122.00K | -114.40K | -130.80K | -114.40K | -113.60K |
EBIT | -122.00K | -114.40K | -130.80K | -114.40K | -113.60K |
EBITDA | -- | -- | -- | -- | -- |
EPS Basic | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EPS Diluted | 0.00 | 0.00 | 0.00 | -0.01 | 0.00 |
Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Basic Shares Outstanding | 29.27M | 29.27M | 29.27M | 29.27M | 29.27M |
Average Diluted Shares Outstanding | 29.27M | 29.27M | 29.27M | 29.27M | 29.27M |
Dividend Per Share | -- | -- | -- | -- | -- |
Payout Ratio | -- | -- | -- | -- | -- |